Prostate cancer usually grows slowly over many years, so a study was designed to find out if it is safe to delay treatment for many years. More than 1,600 men diagnosed with localized prostate cancer (that had not spread beyond the prostate) were randomly assigned to receive surgery, radiation or waiting with active monitoring. Fifteen years later, there was no statistical difference in deaths from prostate cancer between the three groups: 3.1 percent in the active-waiting group, 2.2 percent in the surgery group, and 2.9 percent in the radiation group. More than 97 percent of the men were still alive, regardless of which treatment they received
Rationale for Delaying Prostate Cancer Treatment
Many other studies have also found that long-term active waiting for localized prostate cancer can be safe
My Recommendations
Prostate cancer usually does not kill a man as long as it stays in the prostate; it kills by spreading to another organ and destroying that organ. The most common metastatic sites are bone (84 percent), distant lymph nodes (10.6 percent), liver (10.2 percent), or thorax (9.1 percent). Overall, 18.4 percent of patients who had prostate cancer spread had multiple metastatic sites